1. Home
  2. PDS vs VRDN Comparison

PDS vs VRDN Comparison

Compare PDS & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$92.57

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$15.67

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
VRDN
Founded
1951
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
PDS
VRDN
Price
$92.57
$15.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
$122.33
$35.46
AVG Volume (30 Days)
81.6K
2.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,706,000.00
Revenue This Year
$5.66
$13.73
Revenue Next Year
$2.31
$279.00
P/E Ratio
$884.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.00
$13.18
52 Week High
$103.80
$34.29

Technical Indicators

Market Signals
Indicator
PDS
VRDN
Relative Strength Index (RSI) 48.37 42.93
Support Level $88.08 $15.65
Resistance Level $102.75 $18.05
Average True Range (ATR) 3.76 0.86
MACD 0.06 -0.05
Stochastic Oscillator 31.32 6.56

Price Performance

Historical Comparison
PDS
VRDN

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: